US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
US4845079A
(en)
|
1985-01-23 |
1989-07-04 |
Luly Jay R |
Peptidylaminodiols
|
US5066643A
(en)
|
1985-02-19 |
1991-11-19 |
Sandoz Ltd. |
Fluorine and chlorine statine or statone containing peptides and method of use
|
US4894437A
(en)
|
1985-11-15 |
1990-01-16 |
The Upjohn Company |
Novel renin inhibiting polypeptide analogs containing S-aryl-D- or L- or DL-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties
|
US4885292A
(en)
|
1986-02-03 |
1989-12-05 |
E. R. Squibb & Sons, Inc. |
N-heterocyclic alcohol renin inhibitors
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US4980283A
(en)
|
1987-10-01 |
1990-12-25 |
Merck & Co., Inc. |
Renin-inhibitory pepstatin phenyl derivatives
|
US5089471A
(en)
|
1987-10-01 |
1992-02-18 |
G. D. Searle & Co. |
Peptidyl beta-aminoacyl aminodiol carbamates as anti-hypertensive agents
|
US5034512A
(en)
|
1987-10-22 |
1991-07-23 |
Warner-Lambert Company |
Branched backbone renin inhibitors
|
US5063207A
(en)
|
1987-10-26 |
1991-11-05 |
Warner-Lambert Company |
Renin inhibitors, method for using them, and compositions containing them
|
US5055466A
(en)
|
1987-11-23 |
1991-10-08 |
E. R. Squibb & Sons, Inc. |
N-morpholino derivatives and their use as anti-hypertensive agents
|
US5036054A
(en)
|
1988-02-11 |
1991-07-30 |
Warner-Lambert Company |
Renin inhibitors containing alpha-heteroatom amino acids
|
US5036053A
(en)
|
1988-05-27 |
1991-07-30 |
Warner-Lambert Company |
Diol-containing renin inhibitors
|
DE3841520A1
(de)
|
1988-12-09 |
1990-06-13 |
Hoechst Ag |
Enzymhemmende harnstoffderivate von dipeptiden, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
|
US5106835A
(en)
|
1988-12-27 |
1992-04-21 |
American Cyanamid Company |
Renin inhibitors
|
US5063208A
(en)
|
1989-07-26 |
1991-11-05 |
Abbott Laboratories |
Peptidyl aminodiol renin inhibitors
|
US5194596A
(en)
|
1989-07-27 |
1993-03-16 |
California Biotechnology Inc. |
Production of vascular endothelial cell growth factor
|
FR2650598B1
(fr)
|
1989-08-03 |
1994-06-03 |
Rhone Poulenc Sante |
Derives de l'albumine a fonction therapeutique
|
US5098924A
(en)
|
1989-09-15 |
1992-03-24 |
E. R. Squibb & Sons, Inc. |
Diol sulfonamide and sulfinyl renin inhibitors
|
US5104869A
(en)
|
1989-10-11 |
1992-04-14 |
American Cyanamid Company |
Renin inhibitors
|
US5350836A
(en)
|
1989-10-12 |
1994-09-27 |
Ohio University |
Growth hormone antagonists
|
US5114937A
(en)
|
1989-11-28 |
1992-05-19 |
Warner-Lambert Company |
Renin inhibiting nonpeptides
|
US5064965A
(en)
|
1990-03-08 |
1991-11-12 |
American Home Products Corporation |
Renin inhibitors
|
US5095119A
(en)
|
1990-03-08 |
1992-03-10 |
American Home Products Corporation |
Renin inhibitors
|
US5075451A
(en)
|
1990-03-08 |
1991-12-24 |
American Home Products Corporation |
Pyrrolimidazolones useful as renin inhibitors
|
US5071837A
(en)
|
1990-11-28 |
1991-12-10 |
Warner-Lambert Company |
Novel renin inhibiting peptides
|
US5288931A
(en)
*
|
1991-12-06 |
1994-02-22 |
Genentech, Inc. |
Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
WO1994003599A1
(en)
|
1992-08-04 |
1994-02-17 |
Sagami Chemical Research Center |
HUMAN cDNA AND PROTEIN WHICH SAID cDNA CODES FOR
|
US6180602B1
(en)
|
1992-08-04 |
2001-01-30 |
Sagami Chemical Research Center |
Human novel cDNA, TGF-beta superfamily protein encoded thereby and the use of immunosuppressive agent
|
JPH07250688A
(ja)
|
1994-01-28 |
1995-10-03 |
Sagami Chem Res Center |
TGF−βスーパーファミリー蛋白質をコードするヒト新規cDNA
|
JPH07258293A
(ja)
|
1994-03-23 |
1995-10-09 |
Asahi Chem Ind Co Ltd |
新規な蛋白質ならびにその製造方法
|
US5994102A
(en)
|
1994-12-15 |
1999-11-30 |
Human Genome Sciences, Inc. |
Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
|
US6521227B1
(en)
|
1999-11-18 |
2003-02-18 |
Peter L. Hudson |
Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
|
WO1996018730A1
(en)
|
1994-12-15 |
1996-06-20 |
Human Genome Sciences, Inc. |
Prostatic growth factor
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
ATE423788T1
(de)
|
1995-06-22 |
2009-03-15 |
St Vincents Hosp Sydney |
Neues tgf-beta-ahnliches cytokin
|
US6524802B1
(en)
|
1996-03-29 |
2003-02-25 |
The Johns Hopkins University School Of Medicine |
Methods of detecting growth differentiation factor-14
|
KR20000038040A
(ko)
|
1996-09-11 |
2000-07-05 |
오르토-맥네일 파마슈티칼 인코퍼레이티드 |
전립선 암을 치료하기 위한 tnf-베타-형 단백질, 및 관련 핵산 분자, 약제학적 조성물 및 방법
|
AU6691798A
(en)
|
1997-03-07 |
1998-09-22 |
Metabasis Therapeutics, Inc. |
Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase
|
WO1998039344A1
(en)
|
1997-03-07 |
1998-09-11 |
Metabasis Therapeutics, Inc. |
Novel purine inhibitors of fructose-1,6-bisphosphatase
|
ES2210728T3
(es)
|
1997-03-07 |
2004-07-01 |
Metabasis Therapeutics, Inc. |
Nuevos inhibidores bencimidazol de la fructosa-1, 6-bifosfatasa.
|
WO1999006445A1
(en)
|
1997-07-31 |
1999-02-11 |
The Johns Hopkins University School Of Medicine |
Growth differentiation factor-15
|
WO2000005259A1
(en)
|
1998-07-23 |
2000-02-03 |
Smithkline Beecham Corporation |
Secreted cysteine rich protein-6 (scrp-6)
|
DK1112275T3
(da)
|
1998-09-09 |
2003-11-24 |
Metabasis Therapeutics Inc |
Hidtil ukendte heteroaromatiske inhibitorer for fructose-1,6-bisphosphatase
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
US6465181B2
(en)
|
1999-03-25 |
2002-10-15 |
Abbott Laboratories |
Reagents and methods useful for detecting diseases of the prostate
|
US6974684B2
(en)
|
2001-08-08 |
2005-12-13 |
Curagen Corporation |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
CA2372119A1
(en)
|
1999-05-17 |
2000-11-23 |
Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Und Zum Vertrie B Von Pharmaka Mbh |
Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily
|
GB9912350D0
(en)
*
|
1999-05-26 |
1999-07-28 |
European Molecular Biology Lab Embl |
Modified cytokine
|
KR100581574B1
(ko)
|
2000-03-22 |
2006-05-22 |
옥타게네 게엠베하 |
인간 세포주 내 재조합 혈액 응고 인자의 제조
|
JP2003530838A
(ja)
|
2000-04-12 |
2003-10-21 |
ヒューマン ゲノム サイエンシズ インコーポレイテッド |
アルブミン融合タンパク質
|
ATE470863T1
(de)
|
2000-04-20 |
2010-06-15 |
St Vincents Hosp Sydney |
Diagnostischer assay mit makrophagenhemmendem zytokin-1 (mic-1)
|
WO2002020759A2
(en)
|
2000-09-08 |
2002-03-14 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
A non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
|
US7276593B2
(en)
|
2000-12-29 |
2007-10-02 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
TW200526779A
(en)
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
WO2002072608A2
(en)
|
2001-03-09 |
2002-09-19 |
University Of Chicago |
POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
|
EP2292655B1
(de)
|
2001-05-11 |
2012-03-14 |
Amgen SF, LLC |
Peptide und damit zusammenhängende an Tall-1 bindende Moleküle
|
FI117667B
(fi)
*
|
2001-07-05 |
2007-01-15 |
Univ Zuerich |
Farmaseuttinen koostumus, joka soveltuu käytettäväksi ortopediassa ja hammaslääketieteessä
|
US20030053431A1
(en)
|
2001-09-10 |
2003-03-20 |
Lila Madour |
Method for performing handoff in a radio telecommunications network
|
CA2471363C
(en)
|
2001-12-21 |
2014-02-11 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US20060253913A1
(en)
|
2001-12-21 |
2006-11-09 |
Yue-Jin Huang |
Production of hSA-linked butyrylcholinesterases in transgenic mammals
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
US7919084B2
(en)
|
2002-06-17 |
2011-04-05 |
St. Vincent's Hospital Sydney Limited |
Methods of diagnosis, prognosis and treatment of cardiovascular disease
|
US7157235B2
(en)
|
2002-06-17 |
2007-01-02 |
St. Vincent's Hospital Sydney Limited |
Methods of diagnosis, prognosis and treatment of cardiovascular disease
|
CN1241946C
(zh)
|
2002-07-01 |
2006-02-15 |
美国福源集团 |
对多种细胞具刺激增生作用的人血清白蛋白重组融合蛋白
|
CA2504508A1
(en)
|
2002-11-08 |
2004-05-27 |
Barnes-Jewish Hospital |
Methods and compositions for prostate epithelial cell differentiation
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
EP2774620A1
(de)
|
2004-04-13 |
2014-09-10 |
St Vincent's Hospital Sydney Limited |
Verfahren zum Modulieren der Gewichtsabnahme
|
US20090042780A1
(en)
|
2004-05-20 |
2009-02-12 |
Acceleron Pharma Inc |
Modified TGF-Beta Superfamily Polypeptides and Related Methods
|
US7670595B2
(en)
|
2004-06-28 |
2010-03-02 |
Merck Patent Gmbh |
Fc-interferon-beta fusion proteins
|
CN101724071A
(zh)
|
2004-10-08 |
2010-06-09 |
杜门蒂斯有限公司 |
抗肿瘤坏死因子受体1的单域抗体及其使用方法
|
EP1844337B1
(de)
|
2005-01-24 |
2013-07-03 |
Pepscan Systems B.V. |
Bindende verbindungen, immunogene wirkstoffe und peptidmimetika
|
JP2007258293A
(ja)
|
2006-03-22 |
2007-10-04 |
Fuji Electric Holdings Co Ltd |
はんだ濡れ性評価装置およびはんだ濡れ性評価方法
|
DK2004683T3
(en)
|
2006-03-24 |
2016-08-22 |
Biogen Hemophilia Inc |
PC5 AS A FACTOR IX PROPEPTID PROCESSING ENZYM
|
US8974748B2
(en)
|
2007-04-05 |
2015-03-10 |
Corning Incorporated |
Dual inlet microchannel device and method for using same
|
US7754689B2
(en)
|
2006-06-02 |
2010-07-13 |
Wyeth Llc |
Finger-1 peptide analogs of the TGF-β superfamily
|
MX2008015263A
(es)
|
2006-06-02 |
2008-12-17 |
Wyeth Corp |
Uso de proteinas y pepetidos de la superfamilia del factor beta transformador de crecimiento para purificacion y metodos terapeuticos.
|
WO2008013454A2
(en)
|
2006-07-26 |
2008-01-31 |
Pepscan Systems B.V. |
Immunogenic compounds and protein mimics
|
CA2660691C
(en)
|
2006-08-04 |
2020-01-14 |
Medizinische Hochschule Hannover |
Means and methods for assessing the risk of cardiac interventions based on gdf-15
|
ES2400282T3
(es)
|
2007-04-25 |
2013-04-08 |
Stem Cells Spin S.A. |
Nueva línea de células madre y su aplicación
|
BRPI0814465B1
(pt)
|
2007-07-26 |
2021-11-23 |
Novagen Holding Corporation |
Proteína de fusão, dímero, método para produzir uma proteína de fusão, linhagem de célula, usos de uma proteína de fusão e de uma composição farmacêutica e composição farmacêutica
|
ES2346178T3
(es)
|
2007-07-31 |
2015-11-02 |
Affibody Ab |
Nuevas composiciones, procedimientos y usos de unión de la albúmina
|
EP2187933A4
(de)
|
2007-08-16 |
2010-12-08 |
St Vincents Hosp Sydney |
Mittel und verfahren zur modulierung der aktivität von makrophagen hemmendem zytokin (mic-1)
|
JP2011502106A
(ja)
|
2007-10-09 |
2011-01-20 |
セントビンセンツ ホスピタル シドニー リミテッド |
マクロファージ阻害性サイトカイン−1を除去又は不活性化して悪液質を治療する方法
|
JP5272011B2
(ja)
|
2007-10-22 |
2013-08-28 |
セントビンセンツ ホスピタル シドニー リミテッド |
予後判定の方法
|
US8415118B2
(en)
|
2007-10-29 |
2013-04-09 |
Virginia Tech Intellectual Properties, Inc. |
Porcine DC-SIGN, ICAM-3 and LSECtin and uses thereof
|
PL2235064T3
(pl)
|
2008-01-07 |
2016-06-30 |
Amgen Inc |
Sposób otrzymywania cząsteczek przeciwciał z heterodimerycznymi fc z zastosowaniem kierujących efektów elektrostatycznych
|
EP2242505A4
(de)
|
2008-01-08 |
2012-03-07 |
Biogenerix Ag |
Glykokonjugation von polypeptiden unter verwendung von oligosaccharyltransferasen
|
JP2011509403A
(ja)
|
2008-01-08 |
2011-03-24 |
エフ.ホフマン−ラ ロシュ アーゲー |
Gdf−15に基づいて救急室を受診する患者のリスクを評価するための手段及び方法
|
KR20100132535A
(ko)
|
2008-03-31 |
2010-12-17 |
글락소 그룹 리미티드 |
약물 융합체 및 컨주게이트
|
EP2279419A1
(de)
|
2008-05-20 |
2011-02-02 |
Roche Diagnostics GmbH |
Gdf-15 als biomarker für typ-1-diabetes
|
EP2318844A1
(de)
|
2008-07-14 |
2011-05-11 |
Roche Diagnostics GmbH |
Multimarkerpanel zur diagnose, überwachung und auswahl der therapie für patienten mit herzinsuffizienz
|
WO2010019263A2
(en)
*
|
2008-08-15 |
2010-02-18 |
Genzyme Corporation |
Soluble flt constructs for treating cancers
|
US9012218B2
(en)
|
2008-10-31 |
2015-04-21 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells
|
US20120107420A1
(en)
|
2008-10-31 |
2012-05-03 |
St Vincent's Hospital Sydney Limited |
Methods of prognosis in chronic kidney disease
|
EP2209003A1
(de)
|
2009-01-16 |
2010-07-21 |
F. Hoffmann-Roche AG |
Mittel und Verfahren zur Differenzierung zwischen Fibrose und Zirrhose
|
EP2211182A1
(de)
|
2009-01-16 |
2010-07-28 |
Roche Diagnostics GmbH |
Verfahren zur Bewertung des Schweregrades einer Leberzirrhose
|
EP2396025A2
(de)
|
2009-02-12 |
2011-12-21 |
Stryker Corporation |
Periphere verabreichung von proteinen einschliesslich mitglieder der tgf-beta-superfamilie zur systemischen behandlung von störungen und erkrankungen
|
GB0902737D0
(en)
|
2009-02-19 |
2009-04-01 |
Univ Gent |
GDF15 as a differential marker for spondyloarthropathy
|
KR101558642B1
(ko)
|
2009-02-24 |
2015-10-12 |
솔크 인스티튜트 포 바이올로지칼 스터디즈 |
Tgf-베타 슈퍼패밀리의 설계자 리간드
|
KR101860572B1
(ko)
|
2009-05-05 |
2018-05-24 |
암젠 인크 |
Fgf21 돌연변이체 및 이의 용도
|
EP2451840B1
(de)
|
2009-07-08 |
2018-12-26 |
Amgen Inc. |
Design von stabilen und aggregationsfreien antikörper-fc-modulen durch ch3-domänen-schnittstellendesign
|
WO2011008956A2
(en)
|
2009-07-15 |
2011-01-20 |
Zirus, Inc. |
Mammalian genes involved in infection
|
WO2011050407A1
(en)
|
2009-10-28 |
2011-05-05 |
St Vincent's Hospital Sydney Limited |
Methods of diagnosing and prognosing colonic polyps
|
EP2496601B1
(de)
|
2009-11-05 |
2017-06-07 |
F. Hoffmann-La Roche AG |
Methoden und zusammensetzung zur sekretion heterologer polypeptide
|
KR101791430B1
(ko)
|
2009-11-30 |
2017-10-30 |
얀센 바이오테크 인코포레이티드 |
이펙터 기능이 제거된 항체 Fc 돌연변이체
|
WO2011064758A2
(en)
|
2009-11-30 |
2011-06-03 |
Pfizer Limited |
Fusion protein
|
US9212221B2
(en)
|
2010-03-03 |
2015-12-15 |
Detroit R & D, Inc. |
Form-specific antibodies for NAG-1 (MIC-1, GDF-15), H6D and other TGF-β subfamily and heart disease and cancer diagnoses
|
JP5791335B2
(ja)
|
2010-04-07 |
2015-10-07 |
花王株式会社 |
オルガノポリシロキサン化合物の製造方法
|
WO2011127458A2
(en)
|
2010-04-09 |
2011-10-13 |
University Of Southern California |
Systems and methods of cell activated, controlled release delivery of growth factors for tissue repair and regeneration
|
EP2383571A1
(de)
|
2010-05-02 |
2011-11-02 |
Prof. Hess Medical Consulting GmbH |
Wachstumsdifferenzierungsfaktor 15 (GDF 15) zur Risikovorhersage für diabetischen Fußulkus
|
CN103080746B
(zh)
|
2010-08-26 |
2015-07-15 |
弗·哈夫曼-拉罗切有限公司 |
生物标志物在评估从动脉高血压向心力衰竭的早期转变中的用途
|
EP2439535A1
(de)
|
2010-10-07 |
2012-04-11 |
F. Hoffmann-La Roche AG |
Diagnose von Herzerkrankungen im Zusammenhang mit Diabetes und GDF-15 und Troponin als Prädiktor für die Entwicklung von Diabetes mellitus Typ 2
|
US9732143B2
(en)
*
|
2011-02-03 |
2017-08-15 |
Xoma Technology Ltd. |
Methods and materials for enhancing functional protein expression in bacteria
|
EP2694092B1
(de)
|
2011-04-08 |
2017-01-04 |
Amgen Inc. |
Verfahren zur behandlung oder linderung von stoffwechselstörungen mithilfe des wachstumsdifferenzierungsfaktors 15 (gdf-15)
|
PT2697257T
(pt)
|
2011-04-13 |
2016-12-28 |
Bristol Myers Squibb Co |
Proteínas de fusão fc compreendendo novos ligantes ou arranjos
|
EP2728002B1
(de)
|
2011-06-30 |
2022-01-19 |
Chugai Seiyaku Kabushiki Kaisha |
Heterodimerisiertes polypeptid
|
SG194932A1
(en)
|
2011-06-30 |
2013-12-30 |
Genentech Inc |
Anti-c-met antibody formulations
|
BR112014018575A2
(pt)
|
2012-01-26 |
2017-07-04 |
Amgen Inc |
polipetídeos de fator de diferenciação de crescimento 15 (gdf-15)
|
EP2830646B1
(de)
|
2012-03-27 |
2018-03-07 |
NGM Biopharmaceuticals, Inc. |
Zusammensetzungen und verfahren zur behandlung von stoffwechselerkrankungen
|
ES2784223T3
(es)
|
2012-06-20 |
2020-09-23 |
Univ Virginia Patent Foundation |
Composiciones y procedimientos para regular la homeostasis de glucosa y la acción de insulina
|
WO2014000042A1
(en)
|
2012-06-27 |
2014-01-03 |
Prince Henry's Institute Of Medical Research |
COMPOSITIONS AND METHODS FOR MODIFYING TGF-β FAMILY LIGANDS
|
MA20150232A1
(fr)
|
2012-08-08 |
2015-07-31 |
Roche Glycart Ag |
Protéines de fusion de l'interleukine-10 et leurs utilisations
|
CA2896076C
(en)
|
2012-12-21 |
2022-12-06 |
Aveo Pharmaceuticals, Inc. |
Anti-gdf15 antibodies
|
WO2014120619A2
(en)
|
2013-01-30 |
2014-08-07 |
Ngm Biopharmaceuticals, Inc. |
Compositions and methods of use in treating metabolic disorders
|
US9161966B2
(en)
|
2013-01-30 |
2015-10-20 |
Ngm Biopharmaceuticals, Inc. |
GDF15 mutein polypeptides
|
JP6456356B2
(ja)
|
2013-03-15 |
2019-01-23 |
ジェネンテック, インコーポレイテッド |
IL−22ポリペプチド及びIL−22Fc融合タンパク質並びに使用方法
|
CN203123206U
(zh)
|
2013-04-01 |
2013-08-14 |
宋艳丽 |
一种简易式一次性防污染无菌注射器
|
PT3027642T
(pt)
|
2013-07-31 |
2020-10-30 |
Amgen Inc |
Construtos do fator 15 de diferenciação de crescimento (gdf-15)
|
CN105658664A
(zh)
*
|
2013-07-31 |
2016-06-08 |
美国安进公司 |
含有Fc的多肽的稳定化
|
CN106573966B
(zh)
|
2014-07-30 |
2022-03-01 |
Ngm生物制药有限公司 |
用于治疗代谢异常的组合物和方法
|
MD20170035A2
(ro)
|
2014-10-31 |
2017-09-30 |
Ngm Biopharmaceuticals Inc |
Compoziţii şi metode de utilizare pentru tratamentul tulburărilor metabolice
|
JP6946304B2
(ja)
|
2015-12-22 |
2021-10-06 |
ノバルティス アーゲー |
増殖分化因子15(gdf−15)を使用して代謝障害を処置するまたは軽快させる方法
|